BridgeMD
Compares treatment options for Hypoxia
Official title Endotracheal Tube Suctioning Versus No Suctioning During Emergence From General Anesthesia
ClinicalTrials.gov ID: NCT07287293
What this study is testing
- What it's testing
- The goal of this study is to determine whether omitting tracheal suctioning immediately prior to extubation is non-inferior to routine tracheal suctioning with respect to early postoperative oxygenation among adult surgical patients (aged 18-90 years, American Society of Anesthesiologists [ASA] physical status I-III) undergoing elective surgery under general anesthesia with endotracheal intubation. The study addresses the following questions: Primary outcome (non-inferiority): Is the risk of postoperative desaturation (oxygen saturation [SpO₂] \<92% within 60 minutes after extubation) in the no-suction group not worse than in the routine-suction group by more than 10 percentage points?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18-90 years with American Society of Anesthesiologists (ASA) physical status I-III.
- Scheduled for elective surgery under general anesthesia requiring endotracheal intubation.
- Planned tracheal extubation in the operating room at the end of surgery.
You likely can't join if
- Inability to provide informed consent or the presence of a significant language barrier that prevents effective communication with the clinical team.
- Known diagnosis of obstructive sleep apnea (OSA), active pneumonia, or chronic pulmonary disease (e.g., chronic obstructive pulmonary disease...
- Body mass index (BMI) \>35 kg/m².
- Pregnancy or increased aspiration risk (e.g., full stomach).
- Scheduled for maxillofacial, head and neck, or airway surgery.
- Anticipated surgical duration \>3.5 hours.
See the full eligibility criteria
- Adults aged 18-90 years with American Society of Anesthesiologists (ASA) physical status I-III.
- Scheduled for elective surgery under general anesthesia requiring endotracheal intubation.
- Planned tracheal extubation in the operating room at the end of surgery.
- Inability to provide informed consent or the presence of a significant language barrier that prevents effective communication with the clinical team.
- Known diagnosis of obstructive sleep apnea (OSA), active pneumonia, or chronic pulmonary disease (e.g., chronic obstructive pulmonary disease, restrictive lung disease).
- Body mass index (BMI) \>35 kg/m².
- Pregnancy or increased aspiration risk (e.g., full stomach).
- Scheduled for maxillofacial, head and neck, or airway surgery.
- Anticipated surgical duration \>3.5 hours.
- Anticipated difficult airway, defined as the presence of ≥2 predictors of difficult mask ventilation (DMV) based on Langeron et al., or a documented history of difficult intubation.
The study team makes the final eligibility decision.
Where it's taking place
- Samut Sakhon, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Samut Sakhon, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.